BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2013

Feb 14, 2013

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-10-23

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Business Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-10-23	Employee Stock Option	$26.49	G	280000	Acquired	2021-05-11	Common Stock (280000)	Indirect
2012-10-23	Employee Stock Option	$37.46	G	140000	Acquired	2022-05-07	Common Stock (140000)	Indirect

Footnotes

F1: The option was granted on 5/12/11. It vested 6/48 six months after grant, and vest 1/48 each month thereater.

F2: The option was granted on 5/8/12. It vested 6/48 six months after grant, and vest 1/48 each month thereater.

F3: Stock option exercises completed by reporting person between October 24, 2012 to December 31, 2012 were inadvertently reported on Form 4s as transactions for the reporting person's direct holdings and should have been reported as transactions for the reporting person's indirect holding in Bienaime Family trust following the October 23, 2012 gift of all outstanding stock options held directly to the Bienieme Family Trust.

F4: This is part 2 of 2 of the reporting person's Form 5 filed with the SEC on February 14, 2013.